Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Navar

Showing results (591-600 of 711) with videos related to

Pageof 72
Sort By:
Circulation|November 15, 2017
Availability and Use of Shared Data From Cardiometabolic Clinical TrialsMuthiah Vaduganathan, Amulya Nagarur, Arman Qamar, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 6, 2010
Transgenic mice expressing an intracellular fluorescent fusion of angiotensin II demonstrate renal thrombotic microangiopathy and elevated blood pressureK M Redding, B L Chen, A Singh, et al.
Hypertension (Dallas, Tex. : 1979)|April 19, 2017
2-Methoxyestradiol Reduces Angiotensin II-Induced Hypertension and Renal Dysfunction in Ovariectomized Female and Intact Male MiceAjeeth K Pingili, Karen N Davidge, Shyamala Thirunavukkarasu, et al.
Journal of the American College of Cardiology|February 22, 2020
Muscle Complaints or Events in Patients Randomized to Simvastatin or Ezetimibe/SimvastatinMichael G Nanna, Ann Marie Navar, Robert P Giugliano, et al.
JAMA|November 12, 2023
Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a): A Randomized Dose-Ascending Clinical TrialSteven E Nissen, Helle Linnebjerg, Xi Shen, et al.
Clinical Cardiology|May 19, 2021
Patient perceptions and use of non-statin lipid lowering therapy among patients with or at risk for atherosclerotic cardiovascular disease: Insights from the PALM registryAngela Lowenstern, Shuang Li, Ann Marie Navar, et al.
Journal of the American Heart Association|November 10, 2020
Shared Decisions: A Qualitative Study on Clinician and Patient Perspectives on Statin Therapy and Statin-Associated Side EffectsSarah T Ahmed, Julia M Akeroyd, Dhruv Mahtta, et al.
The American Journal of Cardiology|May 16, 2025
Erratum to 'Lipid Management in United States Commercial and Medicare Enrollees With Atherosclerotic Cardiovascular Disease: Treatment Patterns and Low-Density Lipoprotein Cholesterol Control' [The American Journal of Cardiology 242 (2025) 1-9]Ann Marie Navar, Batul Electricwala, Jasjit K Multani, et al.
Water, Air, and Soil Pollution|July 21, 2015
Biotransformation of Endocrine-Disrupting Compounds in Groundwater: Bisphenol A, Nonylphenol, Ethynylestradiol and Triclosan by a Laccase Cocktail from <i>Pycnoporus sanguineus</i> CS43R Garcia-Morales, M Rodríguez-Delgado, K Gomez-Mariscal, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 25, 2023
Renin-angiotensin-aldosterone system function in the pig-to-baboon kidney xenotransplantation modelChristophe Hansen-Estruch, Mohamed H Bikhet, Mariyam Javed, et al.
Pageof 72

Showing results (591-600 of 711) with videos related to

Sort By:
Pageof 72
Circulation|November 15, 2017
Availability and Use of Shared Data From Cardiometabolic Clinical TrialsMuthiah Vaduganathan, Amulya Nagarur, Arman Qamar, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 6, 2010
Transgenic mice expressing an intracellular fluorescent fusion of angiotensin II demonstrate renal thrombotic microangiopathy and elevated blood pressureK M Redding, B L Chen, A Singh, et al.
Hypertension (Dallas, Tex. : 1979)|April 19, 2017
2-Methoxyestradiol Reduces Angiotensin II-Induced Hypertension and Renal Dysfunction in Ovariectomized Female and Intact Male MiceAjeeth K Pingili, Karen N Davidge, Shyamala Thirunavukkarasu, et al.
Journal of the American College of Cardiology|February 22, 2020
Muscle Complaints or Events in Patients Randomized to Simvastatin or Ezetimibe/SimvastatinMichael G Nanna, Ann Marie Navar, Robert P Giugliano, et al.
JAMA|November 12, 2023
Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a): A Randomized Dose-Ascending Clinical TrialSteven E Nissen, Helle Linnebjerg, Xi Shen, et al.
Clinical Cardiology|May 19, 2021
Patient perceptions and use of non-statin lipid lowering therapy among patients with or at risk for atherosclerotic cardiovascular disease: Insights from the PALM registryAngela Lowenstern, Shuang Li, Ann Marie Navar, et al.
Journal of the American Heart Association|November 10, 2020
Shared Decisions: A Qualitative Study on Clinician and Patient Perspectives on Statin Therapy and Statin-Associated Side EffectsSarah T Ahmed, Julia M Akeroyd, Dhruv Mahtta, et al.
The American Journal of Cardiology|May 16, 2025
Erratum to 'Lipid Management in United States Commercial and Medicare Enrollees With Atherosclerotic Cardiovascular Disease: Treatment Patterns and Low-Density Lipoprotein Cholesterol Control' [The American Journal of Cardiology 242 (2025) 1-9]Ann Marie Navar, Batul Electricwala, Jasjit K Multani, et al.
Water, Air, and Soil Pollution|July 21, 2015
Biotransformation of Endocrine-Disrupting Compounds in Groundwater: Bisphenol A, Nonylphenol, Ethynylestradiol and Triclosan by a Laccase Cocktail from <i>Pycnoporus sanguineus</i> CS43R Garcia-Morales, M Rodríguez-Delgado, K Gomez-Mariscal, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 25, 2023
Renin-angiotensin-aldosterone system function in the pig-to-baboon kidney xenotransplantation modelChristophe Hansen-Estruch, Mohamed H Bikhet, Mariyam Javed, et al.
Pageof 72